Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy

Bilateral choroidal neovascularization associated with optic nerve head drusen treated by antivascular endothelial growth factor therapy

Barbara Delas, Lorena Almud&iacute;, Anabel Carreras, Mouafk AsaadOphthalmology Service, Hospital de Terrassa, Barcelona, SpainObjective: To report a good clinical outcome in a patient with bilateral choroidal neovascularization (CNV) associated with optic nerve head drusen (ONHD) treated wi...

Full description

Bibliographic Details
Main Authors:	Carreras A, Almud&iacute; L, Delas B, Asaad M
Format:	Article
Language:	English
Published:	Dove Medical Press 2012-02-01
Series:	Clinical Ophthalmology
Online Access:	http://www.dovepress.com/bilateral-choroidal-neovascularization-associated-with-optic-nerve-hea-a9251

Similar Items

Peripapillary Choroidal Neovascularization Associated with Optic Nerve Head Drusen Treated with Anti-VEGF Agents
by: Norman A. Saffra, et al.
Published: (2015-02-01)

Antivascular endothelial growth factor in treatment of choroidal osteoma not associated with choroidal neovascular membrane
by: Thomas Cherian, et al.
Published: (2017-01-01)

Role of Intravitreal Antivascular Endothelial Growth Factor Injections for Choroidal Neovascularization due to Choroidal Osteoma
by: Ahmad M. Mansour, et al.
Published: (2014-01-01)

Optic Coherence Tomography Angiography Findings of Bilateral Choroidal Neovascularization Associated with Optic Disc Drusen Treated with Intravitreal Aflibercept Injection
by: Melih Akıdan, et al.
Published: (2020-01-01)

Bilateral optic nerve head drusen with chorioretinal coloboma in the right eye
by: Ali Reza Dehghani, et al.
Published: (2016-01-01)

Complete Resolution of Central Soft Drusen without Geographic Atrophy or Choroidal Neovascularization
by: Garg, I., et al.
Published: (2022)

Cuticular drusen associated with aneurysmal type 1 neovascularization (polypoidal choroidal vasculopathy)
by: Serena Fragiotta, et al.
Published: (2018-12-01)

Central serous papillopathy by optic nerve head drusen
by: Ana Marina Suelves, et al.
Published: (2010-11-01)

Antivascular Endothelial Growth Factor Agents for Neovascular Age-Related Macular Degeneration
by: Ilias Zampros, et al.
Published: (2012-01-01)

Concurrent management of myopic choroidal neovascularization and rhegmatogenous retinal detachment with intravitreal antivascular endothelial growth factor during primary retinal detachment repair
by: Kumar Saurabh, et al.
Published: (2018-01-01)

Bilateral Multifocal Choroidal Osteoma with Choroidal Neovascularization
by: Mousavi MirNaghi, et al.
Published: (2015-01-01)

Incidentally discovered optic nerve head drusen
by: L Gérard, et al.
Published: (2014-11-01)

Commentary: Ziv-aflibercept: An alternative antivascular endothelial growth factor agent for polypoidal choroidal vasculopathy
by: Kumar Anshuman, et al.
Published: (2019-01-01)

Quantitative physiological measurements to evaluate the response of antivascular endothelial growth factor treatment in patients with neovascular diseases
by: In Hwan Hong, et al.
Published: (2017-01-01)

Choroidal Neovascularization: Mechanisms of Endothelial Dysfunction
by: Natalie Jia Ying Yeo, et al.
Published: (2019-11-01)

Combined argon laser photocoagulation and antivascular endothelial growth factor for management of macular polypoidal choroidal vasculopathy
by: Parveen Sen, et al.
Published: (2016-01-01)

Choroidal Osteoma and Secondary Choroidal Neovascularization Treated with Ranibizumab
by: Almila Sarıgül Sezenöz, et al.
Published: (2017-08-01)

Choroidal neovascular membrane in a treated choroidal hemangioma
by: Chokkahalli K Nagesha, et al.
Published: (2016-01-01)

Beals&ndash;Hecht syndrome and choroidal neovascularization
by: Roberto Gallego-Pinazo, et al.
Published: (2010-07-01)

Systematic review with network meta-analysis of antivascular endothelial growth factor use in managing polypoidal choroidal vasculopathy
by: Sheng-Chu Chi, et al.
Published: (2021-02-01)

Optic nerve head drusen masquerading as papilledema: A diagnostic dilemma
by: Vipin Rana, et al.
Published: (2021-01-01)

Intravitreal ranibizumab for treatment of choroidal neovascularization secondary to a bilateral choroidal osteoma
by: Sidra Zafar, et al.
Published: (2016-12-01)

Choroidal neovascularization in patient undergoing growth hormone treatment
by: Jo&atilde;o R de Oliveira Dias, et al.
Published: (2008-08-01)

Can macular translocation be a satisfactory management of subfoveal choroidal neovascular membrane?
by: &Aacute;rp&aacute;d Bereczki, et al.
Published: (2008-06-01)

Central areolar choroidal dystrophy with associated dominant drusen
by: Julie Rodman, et al.
Published: (2013-04-01)

Optical coherence tomography in papilledema and pseudopapilledema with and without optic nerve head drusen
by: Shikha Talwar Bassi, et al.
Published: (2014-01-01)

Commentary: Antivascular endothelial growth factor and retinopathy of prematurity
by: Ajay Indur Dudani, et al.
Published: (2019-01-01)

The Effect of Antivascular Endothelial Growth Factor Therapy on the Development of Neovascular Glaucoma after Central Retinal Vein Occlusion: A Retrospective Analysis
by: Christina L. Ryu, et al.
Published: (2014-01-01)

Evaluation of retinal nerve fiber layer thickness in a patient with bilateral optic disc drusen
by: Alime Gunes, et al.
Published: (2015-06-01)

Choroidal osteoma with choroidal neovascularization treated with bevacizumab in a young male patient
by: Jorge Henrique Cavalcante Tavares, et al.
Published: (2021-01-01)

Response to treatment with intravitreal anti-vascular endothelial growth factors in bilateral exudative cuticular drusen
by: Yusuf K. Durlu, MD.
Published: (2021-06-01)

Choroideremia associated with choroidal neovascularization treated with intravitreal bevacizumab
by: Palejwala NV, et al.
Published: (2014-09-01)

Paediatric choroidal neovascular membrane secondary to toxoplasmosis treated successfully with anti-vascular endothelial growth factor
by: Gaurav Mathur, et al.
Published: (2014-01-01)

Six-Year Real-World Outcomes of Antivascular Endothelial Growth Factor Monotherapy and Combination Therapy for Various Subtypes of Polypoidal Choroidal Vasculopathy
by: Jingyuan Yang, et al.
Published: (2019-01-01)

Use of antivascular endothelial growth factor for diabetic macular edema
by: Rushmia Karim, et al.
Published: (2010-05-01)

Long-Term Visual Outcomes for a Treat-and-Extend Antivascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration: Up to Seven-Year Follow-Up
by: Simon Javidi, et al.
Published: (2020-01-01)

The Role of Optical Coherence Tomography Angiography in Ranibizumab-Treated Choroidal Neovascularization in Choroidal Osteoma
by: William J. Carroll, et al.
Published: (2020-07-01)

Clinical Characteristics of Neovascular Age-Related Macular Degeneration without Typical Drusen
by: Hiroyuki Kamao, et al.
Published: (2021-01-01)

Drusen characteristics of type 2 macular neovascularization in age-related macular degeneration
by: Daniel Ahmed, et al.
Published: (2020-09-01)

Evaluation of optic disc size in patients with optic nerve head drusen using fundus photography
by: Pablo Gili, et al.
Published: (2013-04-01)